Recent News

• 09.02.2025 - Kamada to Participate in Upcoming September Investor Conferences
• 08.13.2025 - Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
• 08.11.2025 - Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
• 08.06.2025 - Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025
• 06.17.2025 - Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
• 05.14.2025 - Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability
• 05.07.2025 - Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

Recent Filings

• 09.02.2025 - EX-99.1 EX-99.1
• 09.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - EX-99.1 EX-99.1
• 06.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 06.17.2025 - EX-99.1 EX-99.1